Microneedling in Combination with Topical Pimecrolimus 1% versus Topical Pimecrolimus 1% for the Treatment of Refractory Stable Vitiligo: A Randomized Clinical Trial.
Fariba IrajiAli AsilianZahra TalebzadehMina SaberFatemeh MokhtariAmir Hossein SiadatSayed Mohsen HosseiniPublished in: Dermatology research and practice (2021)
This study established that combination therapy results in more significant patient improvement. Additionally, one patient experienced mild skin irritation as a side effect of topical pimecrolimus.